Alignment Healthcare, Inc. $ALHC is Persistent Asset Partners Ltd’s 6th Largest Position

Persistent Asset Partners Ltd cut its position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 13.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 227,889 shares of the company’s stock after selling 36,066 shares during the quarter. Alignment Healthcare makes up about 2.4% of Persistent Asset Partners Ltd’s holdings, making the stock its 6th biggest position. Persistent Asset Partners Ltd owned approximately 0.12% of Alignment Healthcare worth $3,190,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the company. Invesco Ltd. lifted its position in shares of Alignment Healthcare by 1,415.7% during the 1st quarter. Invesco Ltd. now owns 1,875,790 shares of the company’s stock worth $34,927,000 after buying an additional 1,752,033 shares in the last quarter. Vanguard Group Inc. increased its position in shares of Alignment Healthcare by 13.2% during the first quarter. Vanguard Group Inc. now owns 11,113,896 shares of the company’s stock valued at $206,941,000 after acquiring an additional 1,295,825 shares during the last quarter. 8 Knots Management LLC lifted its holdings in Alignment Healthcare by 28.9% during the first quarter. 8 Knots Management LLC now owns 4,715,472 shares of the company’s stock worth $87,802,000 after acquiring an additional 1,056,777 shares during the period. Voya Investment Management LLC boosted its position in Alignment Healthcare by 408.3% in the first quarter. Voya Investment Management LLC now owns 1,293,414 shares of the company’s stock worth $24,083,000 after purchasing an additional 1,038,940 shares during the last quarter. Finally, Assenagon Asset Management S.A. grew its stake in Alignment Healthcare by 124.8% in the 2nd quarter. Assenagon Asset Management S.A. now owns 1,869,035 shares of the company’s stock valued at $26,166,000 after purchasing an additional 1,037,638 shares during the period. 86.19% of the stock is owned by institutional investors.

Alignment Healthcare Trading Down 1.5%

Shares of ALHC stock opened at $16.52 on Friday. Alignment Healthcare, Inc. has a 1 year low of $10.18 and a 1 year high of $21.06. The company’s fifty day simple moving average is $16.98 and its two-hundred day simple moving average is $15.41. The company has a debt-to-equity ratio of 1.99, a current ratio of 1.61 and a quick ratio of 1.61. The stock has a market capitalization of $3.31 billion, a price-to-earnings ratio of -137.67 and a beta of 1.17.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Thursday, October 30th. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.03. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.The company had revenue of $993.70 million during the quarter, compared to analysts’ expectations of $980.90 million. During the same period in the previous year, the business earned ($0.14) earnings per share. The firm’s quarterly revenue was up 43.5% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. As a group, analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Insider Buying and Selling at Alignment Healthcare

In related news, CEO John E. Kao sold 355,018 shares of the company’s stock in a transaction that occurred on Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total transaction of $5,825,845.38. Following the sale, the chief executive officer owned 4,533,568 shares of the company’s stock, valued at approximately $74,395,850.88. This represents a 7.26% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Christopher J. Joyce sold 30,939 shares of the stock in a transaction that occurred on Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total transaction of $507,708.99. Following the completion of the sale, the insider owned 343,592 shares in the company, valued at $5,638,344.72. This represents a 8.26% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 7,593,948 shares of company stock worth $122,396,905. 7.00% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

ALHC has been the topic of a number of recent analyst reports. KeyCorp upgraded Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 target price on the stock in a research note on Monday, August 25th. Weiss Ratings restated a “sell (d-)” rating on shares of Alignment Healthcare in a report on Wednesday, October 8th. UBS Group boosted their target price on shares of Alignment Healthcare from $17.00 to $18.00 and gave the company a “neutral” rating in a research note on Friday, October 31st. The Goldman Sachs Group restated a “buy” rating and set a $22.00 price target on shares of Alignment Healthcare in a research note on Monday, November 3rd. Finally, Zacks Research downgraded Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 28th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Alignment Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $19.85.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.